A new scientific analysis found that a COVID-19 mRNA vaccine given during immunotherapy helped people with advanced skin or ...

More than 50% of lung-transplant recipients experience a rejection of their new lung within five years of receiving it, yet ...

A 43-year-old woman from Massachusetts suffering from crippling depression, anxiety and suicidal thoughts was found to have ...

More than 50% of lung-transplant recipients experience a rejection of their new lung within five years of receiving it, yet ...

About 1 in 8 women in the U.S. will have breast cancer in their lifetime, making it the most common cancer among women. So ...

Arcturus Therapeutics reported interim results from a mid-stage study of an mRNA-based treatment for cystic fibrosis that ...

Cardiff Oncology's onvansertib's unique PLK1 inhibition mechanism offers breakthrough potential in multi-billion-dollar ...

After a surprising diagnosis at 43, Joy Woodson turned her experience into a mission to support and inspire others.

Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a ...

Scientists from China and Australia have discovered a treatment that weakens prostate cancer cells, the South China Morning ...

A small study found that drugs like Ozempic, Wegovy, and Mounjaro change the way the body processes alcohol, making it less ...

A day after Diwali, Delhi’s air quality plunged to “very poor” levels with PM2.5 and PM10 spiking across the city. Doctors ...